Endoscopic Nd

YAG laser therapy as palliative treatment for advanced adenocarcinoma of the gastric cardia

David Fleischer, Michael V. Sivak

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Fifteen patients with advanced adenocarcinoma of the gastric cardia were treated with endoscopic neodymium: yttrium aluminum garnet laser therapy. Four patients developed recurrence after previous surgery. In 7 patients, a decision was made at exploration that a palliative operation was not feasible. In the remaining 4 patients, surgery was not considered because of widespread disease or the patient's condition. Fourteen of fifteen were classified as stage IV (tumor, node, metastasis). Tumors ranged in length from 3 to 10 cm (mean 6.3). Luminal opening was 4 mm or less in 12 patients. The mean number of treatments required to alleviate symptoms and remove obstruction was 2.8 (range 1-5) and the mean number of days required was 5.7 (range 1-12). An average of 6129 W/s were given per treatment and the mean total energy was 17,570 W/s. Luminal diameter at the narrowest segment increased from 3.3 mm before treatment to 12.1 mm after treatment. Clinical benefit in terms of increased food intake was demonstrated in all patients. No major complications directly attributable to laser therapy were seen. The overall results are encouraging and hold promise for a patient population in whom the therapeutic options are generally very limited.

Original languageEnglish (US)
Pages (from-to)815-820
Number of pages6
JournalGastroenterology
Volume87
Issue number4
StatePublished - 1984
Externally publishedYes

Fingerprint

Cardia
Solid-State Lasers
Laser Therapy
Palliative Care
Stomach
Adenocarcinoma
Therapeutics
Neodymium
Neoplasms
Eating
Neoplasm Metastasis
Recurrence

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Endoscopic Nd : YAG laser therapy as palliative treatment for advanced adenocarcinoma of the gastric cardia. / Fleischer, David; Sivak, Michael V.

In: Gastroenterology, Vol. 87, No. 4, 1984, p. 815-820.

Research output: Contribution to journalArticle

Fleischer, David ; Sivak, Michael V. / Endoscopic Nd : YAG laser therapy as palliative treatment for advanced adenocarcinoma of the gastric cardia. In: Gastroenterology. 1984 ; Vol. 87, No. 4. pp. 815-820.
@article{a6bec4f316494148b6ec22516004bff9,
title = "Endoscopic Nd: YAG laser therapy as palliative treatment for advanced adenocarcinoma of the gastric cardia",
abstract = "Fifteen patients with advanced adenocarcinoma of the gastric cardia were treated with endoscopic neodymium: yttrium aluminum garnet laser therapy. Four patients developed recurrence after previous surgery. In 7 patients, a decision was made at exploration that a palliative operation was not feasible. In the remaining 4 patients, surgery was not considered because of widespread disease or the patient's condition. Fourteen of fifteen were classified as stage IV (tumor, node, metastasis). Tumors ranged in length from 3 to 10 cm (mean 6.3). Luminal opening was 4 mm or less in 12 patients. The mean number of treatments required to alleviate symptoms and remove obstruction was 2.8 (range 1-5) and the mean number of days required was 5.7 (range 1-12). An average of 6129 W/s were given per treatment and the mean total energy was 17,570 W/s. Luminal diameter at the narrowest segment increased from 3.3 mm before treatment to 12.1 mm after treatment. Clinical benefit in terms of increased food intake was demonstrated in all patients. No major complications directly attributable to laser therapy were seen. The overall results are encouraging and hold promise for a patient population in whom the therapeutic options are generally very limited.",
author = "David Fleischer and Sivak, {Michael V.}",
year = "1984",
language = "English (US)",
volume = "87",
pages = "815--820",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Endoscopic Nd

T2 - YAG laser therapy as palliative treatment for advanced adenocarcinoma of the gastric cardia

AU - Fleischer, David

AU - Sivak, Michael V.

PY - 1984

Y1 - 1984

N2 - Fifteen patients with advanced adenocarcinoma of the gastric cardia were treated with endoscopic neodymium: yttrium aluminum garnet laser therapy. Four patients developed recurrence after previous surgery. In 7 patients, a decision was made at exploration that a palliative operation was not feasible. In the remaining 4 patients, surgery was not considered because of widespread disease or the patient's condition. Fourteen of fifteen were classified as stage IV (tumor, node, metastasis). Tumors ranged in length from 3 to 10 cm (mean 6.3). Luminal opening was 4 mm or less in 12 patients. The mean number of treatments required to alleviate symptoms and remove obstruction was 2.8 (range 1-5) and the mean number of days required was 5.7 (range 1-12). An average of 6129 W/s were given per treatment and the mean total energy was 17,570 W/s. Luminal diameter at the narrowest segment increased from 3.3 mm before treatment to 12.1 mm after treatment. Clinical benefit in terms of increased food intake was demonstrated in all patients. No major complications directly attributable to laser therapy were seen. The overall results are encouraging and hold promise for a patient population in whom the therapeutic options are generally very limited.

AB - Fifteen patients with advanced adenocarcinoma of the gastric cardia were treated with endoscopic neodymium: yttrium aluminum garnet laser therapy. Four patients developed recurrence after previous surgery. In 7 patients, a decision was made at exploration that a palliative operation was not feasible. In the remaining 4 patients, surgery was not considered because of widespread disease or the patient's condition. Fourteen of fifteen were classified as stage IV (tumor, node, metastasis). Tumors ranged in length from 3 to 10 cm (mean 6.3). Luminal opening was 4 mm or less in 12 patients. The mean number of treatments required to alleviate symptoms and remove obstruction was 2.8 (range 1-5) and the mean number of days required was 5.7 (range 1-12). An average of 6129 W/s were given per treatment and the mean total energy was 17,570 W/s. Luminal diameter at the narrowest segment increased from 3.3 mm before treatment to 12.1 mm after treatment. Clinical benefit in terms of increased food intake was demonstrated in all patients. No major complications directly attributable to laser therapy were seen. The overall results are encouraging and hold promise for a patient population in whom the therapeutic options are generally very limited.

UR - http://www.scopus.com/inward/record.url?scp=0021169536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021169536&partnerID=8YFLogxK

M3 - Article

VL - 87

SP - 815

EP - 820

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 4

ER -